{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:32:27Z","timestamp":1781530347700,"version":"3.54.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoantibodies to metabotropic glutamate receptor 5 (mGluR5) are known to be the cause of autoimmune encephalitis, particularly limbic encephalitis, closely related to Hodgkin\u2019s lymphoma (HL). The involvement of peripheral neuropathy is rarely reported. In our case, mGluR5 antibody was found in a Guillain-Barr\u00e9 syndrome (GBS) patient accompanied by severe headache but without neuropsychiatric manifestations or HL. Presenting with severe headache, the patient developed progressive bilateral limb weakness, areflexia, and cranial nerve involvement consisting of eye movement disorder, restricted mouth opening and chewing, bilateral facial paralysis and bulbar palsy. Cerebrospinal fluid (CSF) revealed elevated CSF protein level and normal cell count, known as \u201calbumino-cytological dissociation\u201d. Oligoclonal IgG bands were found in both the CSF and serum. Electrophysiological studies revealed symmetrical sensory and motor neuropathy with a mixture of axonal and demyelinating features. Brain and spinal cord magnetic resonance imaging (MRI), as well as the electroencephalogram, were normal. The mGluR5 antibody was positive in both serum and CSF with a Cell-Based Assay (CBA). The patient responded well to intravenous gammaglobulin therapy, correlated with a reduction of mGluR5 antibody titer from 1:30 to 1:10 in the serum. After 6 months, the patient recovered completely without any sign of recurrence or neoplasm. This first case of mGluR5 antibody-associated GBS accompanied by severe headache shows that mGluR5-associated disorders are not limited to manifestations of limbic encephalitis and HL.<\/jats:p>","DOI":"10.3389\/fimmu.2022.808131","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T06:05:20Z","timestamp":1647842720000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Case Report: Guillain-Barr\u00e9 Syndrome Characterized by Severe Headache Associated With Metabotropic Glutamate Receptor 5 Antibody"],"prefix":"10.3389","volume":"13","author":[{"given":"Weiqian","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hainan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91887-6","article-title":"The Ophelia Syndrome: Memory Loss in Hodgkin's Disease","volume":"1","author":"Carr","year":"1982","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to Metabotropic Glutamate Receptor 5 in the Ophelia Syndrome","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31828ab325","article-title":"Ophelia Syndrome With Metabotropic Glutamate Receptor 5 Antibodies in CSF","volume":"80","author":"Mat","year":"2013","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000865","article-title":"Limbic Encephalitis With Mglur5 Antibodies and Immunotherapy-Responsive Prosopagnosia","volume":"83","author":"Pr\u00fcss","year":"2014","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005614","article-title":"Encephalitis With Mglur5 Antibodies: Symptoms and Antibody Effects","volume":"90","author":"Spatola","year":"2018","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02568","article-title":"Encephalitis Associated to Metabotropic Glutamate Receptor 5 (Mglur5) Antibodies in Cerebrospinal Fluid","volume":"9","author":"Guevara","year":"2018","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and Management of Guillain-Barr\u00e9 Syndrome in Ten Steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 Syndrome: Pathogenesis, Diagnosis, Treatment and Prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 Syndrome and Validation of Brighton Criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2068249316","DOI":"10.1177\/1744806920914204","article-title":"Peripheral Glutamate Receptor and Transient Receptor Potential Channel Mechanisms of Craniofacial Muscle Pain","volume":"16","author":"Chung","year":"2020","journal-title":"Mol Pain"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.779","article-title":"Peripheral Neuropathy in Limbic Encephalitis With Anti-Glutamate Receptor Antibodies: Case Report and Systematic Literature Review","volume":"7","author":"Wei","year":"2017","journal-title":"Brain Behav"},{"key":"B14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neuropharm.2014.08.004","article-title":"Spinal Administration of Mglur5 Antagonist Prevents the Onset of Bortezomib Induced Neuropathic Pain in Rat","volume":"86","author":"Ghelardini","year":"2014","journal-title":"Neuropharmacology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16034642","article-title":"Nerve Demyelination Increases Metabotropic Glutamate Receptor Subtype 5 Expression in Peripheral Painful Mononeuropathy","volume":"16","author":"Ko","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f88345","article-title":"Pain in Guillain-Barre Syndrome: A Long-Term Follow-Up Study","volume":"75","author":"Ruts","year":"2010","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s004150070122","article-title":"Pain in Miller Fisher Syndrome","volume":"247","author":"Koga","year":"2000","journal-title":"J Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00935.x","article-title":"Headache Associated With Miller Fisher Syndrome","volume":"47","author":"Friedman","year":"2007","journal-title":"Headache"},{"key":"B19","doi-asserted-by":"publisher","first-page":"10604","DOI":"10.1038\/ncomms10604","article-title":"Intracellular Mglur5 Plays a Critical Role in Neuropathic Pain","volume":"7","author":"Vincent","year":"2016","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001050","article-title":"Bivalent Ligand That Activates Mu Opioid Receptor and Antagonizes Mglur5 Receptor Reduces Neuropathic Pain in Mice","volume":"158","author":"Peterson","year":"2017","journal-title":"Pain"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.808131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T06:05:25Z","timestamp":1647842725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.808131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":20,"alternative-id":["10.3389\/fimmu.2022.808131"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.808131","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"article-number":"808131"}}